Trademark: 87128871
Word
CANCER
Status Date
Tuesday, March 24, 2020
Filing Date
Friday, August 5, 2016
Published for Opposition
Tuesday, January 24, 2017
Abandoned Date
Tuesday, March 24, 2020
5 Pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of certain blood diseases and cancers
42 Development and testing services in the fields of biotechnology, chemistry and pharmaceuticals; scientific study and research in the fields of the prevention, treatment and management of illness, health care delivery and the scientific aspects of health care policy, health care cost management and financing as these fields impact on quality of health care; research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services for medical and scientific research and development purposes, namely, pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; scientific research services; scientific research, namely, development of pharmaceuticals or diagnostic methods for others
44 Providing on-line information in the field of diagnosis and treatment of cancer; providing an on-line computer database featuring information relating to diagnosis and treatment of cancer; providing medical and pharmaceutical information services; providing links to web sites of others featuring information about the diagnosis and treatment of cancer; providing medical information and pharmaceutical information services, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; health care services, namely, disease management programs that provide counseling and information in the field of pharmaceuticals, and distributing written materials in connection therewith; providing an interactive website featuring medical information that enables users to enter, access, track, monitor and generate health and medical information and reports; providing pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping, all for medical diagnostic and treatment purposes, based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries
45 Providing information concerning consumer product safety via government pharmaceutical programs that provide counseling and information to medical professionals, pharmacists and patients, particularly counseling and information on consumer product safety issues pertaining to pharmaceuticals, and distributing printed materials in connection therewith
The color(s) blue, red, gray, and white is/are claimed as a feature of the mark.
"CANCER"
The mark consists of a red universal prohibition symbol with a blue and white globe inside and the word "CANCER" in white with a red line diagonally through it, all above a gray shadow.
May 28, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
May 28, 2020
Abandonment - No Use Statement Filed
Aug 24, 2019
Notice Of Approval Of Extension Request E-Mailed
Aug 23, 2019
Extension 5 Granted
Aug 19, 2019
Extension 5 Filed
Aug 22, 2019
Case Assigned To Intent To Use Paralegal
Aug 19, 2019
Teas Extension Received
Jan 24, 2019
Notice Of Approval Of Extension Request E-Mailed
Jan 22, 2019
Extension 4 Granted
Jan 22, 2019
Extension 4 Filed
Jan 22, 2019
Teas Extension Received
Oct 5, 2018
Assigned To Examiner
Jul 19, 2018
Notice Of Approval Of Extension Request E-Mailed
Jul 17, 2018
Extension 3 Granted
Jul 17, 2018
Extension 3 Filed
Jul 17, 2018
Teas Extension Received
Jan 25, 2018
Notice Of Approval Of Extension Request E-Mailed
Jan 23, 2018
Extension 2 Granted
Jan 23, 2018
Extension 2 Filed
Jan 23, 2018
Teas Extension Received
Jul 15, 2017
Notice Of Approval Of Extension Request E-Mailed
Jul 13, 2017
Extension 1 Granted
Jul 13, 2017
Extension 1 Filed
Jul 13, 2017
Teas Extension Received
Mar 21, 2017
Noa E-Mailed - Sou Required From Applicant
Jan 24, 2017
Official Gazette Publication Confirmation E-Mailed
Jan 24, 2017
Published For Opposition
Jan 4, 2017
Notification Of Notice Of Publication E-Mailed
Dec 12, 2016
Approved For Pub - Principal Register
Dec 6, 2016
Examiner's Amendment Entered
Dec 6, 2016
Notification Of Examiners Amendment E-Mailed
Dec 6, 2016
Examiners Amendment E-Mailed
Dec 6, 2016
Examiners Amendment -Written
Nov 23, 2016
Teas/Email Correspondence Entered
Nov 23, 2016
Correspondence Received In Law Office
Nov 23, 2016
Teas Response To Office Action Received
Nov 22, 2016
Notification Of Non-Final Action E-Mailed
Nov 22, 2016
Non-Final Action E-Mailed
Nov 22, 2016
Non-Final Action Written
Nov 16, 2016
Assigned To Examiner
Aug 11, 2016
Notice Of Design Search Code E-Mailed
Aug 10, 2016
New Application Office Supplied Data Entered In Tram
Aug 9, 2016
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
